Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GSK

GSK Plc ADR

Feb 09 • 11:22AM ET

59.11

-1.12 -1.86 %

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Feb 06, 12:50 PMGSK wins European Commission approval for Nucala as an add-on maintenance treatment for certain COPD patients, expanding the drug’s indications in the EU.

Peers: JNJ PFE MRK BMY LLY NVS AZN-D ABBV SNY GILD

| Held by: AVDE PPH FENI FVD RODM DFAX AVIV AQEC BINV GMOI

Scroll to Statements

Index	-	P/E	16.13	EPS (ttm)	3.66	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	12.65%
Market Cap	119.23B	Forward P/E	11.10	EPS next Y	5.32	Insider Trans	-	Shs Float	2.02B	Perf Month	17.70%
Enterprise Value	137.92B	PEG	1.87	EPS next Q	1.17	Inst Own	19.41%	Short Float	0.87%	Perf Quarter	25.50%
Income	7.53B	P/S	2.77	EPS this Y	3.65%	Inst Trans	-1.26%	Short Ratio	3.83	Perf Half Y	56.38%
Sales	43.11B	P/B	5.47	EPS next Y	9.29%	ROA	9.61%	Short Interest	17.55M	Perf YTD	20.53%
Book/sh	10.81	P/C	26.03	EPS next 5Y	5.93%	ROE	38.48%	52W High	60.37 -2.09%	Perf Year	62.48%
Cash/sh	2.27	P/FCF	15.13	EPS past 3/5Y	-25.93% 0.08%	ROIC	18.01%	52W Low	32.38 82.55%	Perf 3Y	68.26%
Dividend Est.	1.89 (3.19%)	EV/EBITDA	9.60	Sales past 3/5Y	6.03% -0.31%	Gross Margin	72.53%	Volatility	2.06% 1.69%	Perf 5Y	54.47%
Dividend TTM	1.71 (2.89%)	EV/Sales	3.20	EPS Y/Y TTM	132.14%	Oper. Margin	22.57%	ATR (14)	1.26	Perf 10Y	42.33%
Dividend Ex-Date	Feb 20, 2026	Quick Ratio	0.54	Sales Y/Y TTM	7.51%	Profit Margin	17.47%	RSI (14)	76.98	Recom	2.57
Dividend Gr. 3/5Y	8.77% -7.68%	Current Ratio	0.82	EPS Q/Q	61.53%	SMA20	14.01%	Beta	0.47	Target Price	56.10
Payout	47.15%	Debt/Eq	1.08	Sales Q/Q	10.17%	SMA50	18.07%	Rel Volume	1.86	Prev Close	60.23
Employees	68629	LT Debt/Eq	0.90	Earnings	Feb 04 BMO	SMA200	37.21%	Avg Volume	4.58M	Price	59.11
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.50% 3.23%	Trades		Volume	2,753,291	Change	-1.86%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	Citigroup	Neutral
Jan-06-26	Downgrade	Barclays	Equal Weight → Underweight
Nov-25-25	Upgrade	BofA Securities	Underperform → Neutral
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight

Show Previous Ratings

Today 07:15AM	Citi lifts GSK target price but keeps neutral stance after rally (Proactive)
Feb-06-26 11:45AM	GSK Gets EU Approval for Expanded Use of Nucala in COPD (Zacks)
05:15AM	ShoreCap says GSK has cracked it and the £40bn prize is now in sight (Proactive)
Feb-05-26 09:15AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q4 Earnings? (Zacks)
02:04AM	Analyst Report: GSK plc (Morningstar Research)
09:00PM	Loading…
Feb-04-26 09:00PM	Analyst Report: GSK plc (Morningstar Research) +7.29%
04:05PM	GSK Is Eyeing $55 Billion In Sales And It Has Nothing To Do With Obesity (Investor's Business Daily)
01:52PM	GSK Shares Jump 5.2% as New CEO Signals Faster R&D, Deal Push (GuruFocus.com)
01:50PM	GSK Beats Estimates, Sticks With Long-Term Outlook (GuruFocus.com)
12:01PM	GSK PLC (GSK) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ... (GuruFocus.com)
10:30AM	GSK beat the numbers, but the real story was the guidance (Proactive)
08:31AM	GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook (Zacks)
08:12AM	GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike (Benzinga)
07:27AM	GSK Q4 Earnings Call Highlights (MarketBeat)
07:05AM	GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
02:45AM	Loading…
02:45AM	GSKs Specialty Medicines Drive Solid Results (The Wall Street Journal)
02:20AM	Glaxo: Q4 Earnings Snapshot (Associated Press Finance)
Feb-03-26 12:30PM	Wave Life Sciences price target raised to $50 from $47 at Clear Street (TipRanks)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
07:17AM	GSK PLC (LSE:GSK) Q4 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Feb-02-26 02:16PM	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path (Benzinga)
10:01AM	AstraZeneca Shares Start Trading in US After Listing Upgrade (Bloomberg)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-29-26 10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-28-26 10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
05:51AM	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle (Benzinga)
Jan-27-26 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Jan-22-26 01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
10:23AM	Loading…
Jan-21-26 10:23AM	GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout (Zacks)
10:00AM	GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026 (Business Wire)
Jan-20-26 05:30PM	Why Rapt Therapeutics Stock Soared Today (Motley Fool)
04:05PM	GSK Digs In On Allergies With $2.2 Billion Rapt Therapeutics Buyout (Investor's Business Daily)
01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
09:36AM	Stocks to Watch Tuesday: 3M, Nvidia, Netflix, Warner Bros. (The Wall Street Journal)
09:00AM	GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million (Business Wire)
07:10AM	This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. (Barrons.com)
05:54AM	GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough (Benzinga)
Jan-15-26 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
08:53AM	Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week? (Zacks)
Jan-12-26 01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
09:45AM	Why GSK (GSK) is a Top Growth Stock for the Long-Term (Zacks)
06:15AM	Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSKs B7-H3 Antibody Drug Conjugate (ADC) (Business Wire)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-10-26 02:57PM	Jefferies Reaffirms a Buy Rating on GSK plc (GSK) - Here's Why (Insider Monkey)
Jan-09-26 01:56PM	AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties (Benzinga)
05:10AM	Johnson & Johnson Strikes Deal With White House to Lower Drug Prices (Barrons.com)
Jan-08-26 12:33PM	GSK's Chronic Hepatitis B Drug Meets Goals in Two Late-Stage Studies (Zacks)
Jan-07-26 10:50AM	GSK Scores Phase III Win in Hep B (GuruFocus.com)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jan-06-26 12:48PM	GSK Wins Japan Approval for Exdensur (GuruFocus.com)
11:12AM	MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine (Zacks)
Jan-05-26 02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
Dec-31-25 11:03AM	Pfizer and GSK Lead 2026 U.S. Drug Price Hikes (GuruFocus.com)
09:34AM	Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs (GuruFocus.com)
Dec-30-25 09:40AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
Dec-29-25 11:59PM	Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? (Insider Monkey)
03:28AM	HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target (Insider Monkey)
Dec-24-25 10:33AM	Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know (Zacks)
Dec-22-25 08:27AM	Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals (Zacks)
Dec-19-25 04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
02:50PM	Nine Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
02:50PM	More Big Drugmakers Reach Pricing Deals With White House (The Wall Street Journal)
12:15PM	Pharma's $370B Bet on America: The ETF Plays for 2026 (Zacks)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
08:12AM	Will GILD's Strong HIV Portfolio Reap Rewards in 2026? (Zacks)
Dec-18-25 10:41AM	Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026? (Zacks)
07:41AM	GSK Gains FDA Approval for Exdensur in Severe Eosinophilic Asthma (GuruFocus.com)
07:27AM	GSK's Asthma Drug Gets U.S. Greenlight--$4 Billion Blockbuster in the Making? (GuruFocus.com)
Dec-17-25 10:29AM	GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment (Zacks)
09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-16-25 09:55PM	Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma (Business Wire)
08:53AM	GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal (Zacks)
Dec-15-25 10:49AM	FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer (Zacks)
10:27AM	GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU (Zacks)
Dec-12-25 01:53PM	GSK's $4 Billion Asthma Drug Gets First-Ever Green Light in Europe (GuruFocus.com)
10:08AM	GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea (Zacks)
07:28AM	GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation (Insider Monkey)
03:00AM	US is best place to invest, says boss of British drugs giant (The Telegraph)
Dec-11-25 11:03AM	GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer (Zacks)
09:12AM	GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell? (Zacks)
Dec-10-25 11:28AM	J.P. Morgan Maintains a Sell Rating on GSK plc (GSK) (Insider Monkey)
09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Dec-09-25 09:10AM	How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks (Zacks)
Dec-04-25 11:30AM	Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-25 09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Dec-02-25 09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Dec-01-25 04:21PM	Top Analyst Reports for Palantir, Philip Morris & TotalEnergies (Zacks)
Nov-25-25 07:22PM	U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs (The Wall Street Journal)
04:14AM	BofA upgrades Novartis and GSK as pivotal data, new launches approach (Investing.com)
Nov-21-25 04:46PM	AnaptysBio Reverses Higher After Trading Legal Barbs With Pharma Giant GSK (Investor's Business Daily)
02:37PM	Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. (Investor's Business Daily)
09:47AM	AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK (Investor's Business Daily)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
06:14AM	GSK, AnaptysBio Sue Each Other Over Cancer Drug License (The Wall Street Journal)
Nov-19-25 10:09PM	JPMorgan Lowers GSK Price Target, Maintains Underweight Rating (Insider Monkey)
Nov-18-25 10:33AM	Alector Stock Plummets 63% in a Month: Here's What You Need to Know (Zacks)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience